Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 88,049 | 83,407 | 76,181 | 67,431 | 64,745 |
| Cost of Goods | 45,893 | 43,161 | 38,094 | 34,156 | 33,312 |
| Gross Profit | 42,156 | 40,246 | 38,087 | 33,275 | 31,433 |
| Operating Expenses | 34,570 | 30,874 | 29,491 | 25,507 | 23,361 |
| Operating Income | 8,479 | 9,533 | 8,690 | 7,924 | 8,384 |
| Interest Expense | 389 | 365 | 429 | 917 | 765 |
| Other Income | -440 | 400 | 135 | 133 | 14 |
| Pre-tax Income | 7,650 | 9,568 | 8,396 | 7,140 | 7,633 |
| Income Tax | 2,240 | 1,970 | 1,775 | 899 | 3,115 |
| Net Income Continuous | 5,410 | 7,598 | 6,621 | 6,241 | 4,518 |
| Net Income Discontinuous | -3,737 | -8,952 | -8,962 | -38,118 | -2,189 |
| Net Income | $1,673 | $-1,354 | $-2,341 | $-31,877 | $2,329 |
| EPS Basic Total Ops | 0.05 | -0.04 | -0.08 | -1.05 | 0.08 |
| EPS Basic Continuous Ops | 0.18 | 0.25 | 0.22 | 0.20 | 0.15 |
| EPS Basic Discontinuous Ops | -0.12 | -0.29 | -0.29 | -1.25 | -0.07 |
| EPS Diluted Total Ops | 0.05 | -0.04 | -0.08 | -1.05 | 0.07 |
| EPS Diluted Continuous Ops | 0.17 | 0.24 | 0.21 | 0.20 | 0.15 |
| EPS Diluted Discontinuous Ops | -0.12 | -0.29 | -0.29 | -1.24 | -0.08 |
| EBITDA(a) | $11,846 | $13,007 | $12,027 | $12,961 | $14,730 |